335 related articles for article (PubMed ID: 25172240)
1. Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients.
Kivity S; Zafrir Y; Loebstein R; Pauzner R; Mouallem M; Mayan H
Autoimmun Rev; 2014 Nov; 13(11):1109-13. PubMed ID: 25172240
[TBL] [Abstract][Full Text] [Related]
2. Factors Associated with Myelosuppression Related to Low-Dose Methotrexate Therapy for Inflammatory Rheumatic Diseases.
Mori S; Hidaka M; Kawakita T; Hidaka T; Tsuda H; Yoshitama T; Migita K; Ueki Y
PLoS One; 2016; 11(4):e0154744. PubMed ID: 27128679
[TBL] [Abstract][Full Text] [Related]
3. Severe pancytopenia associated with low-dose methotrexate therapy for rheumatoid arthritis.
Calvo-Romero JM
Ann Pharmacother; 2001 Dec; 35(12):1575-7. PubMed ID: 11793624
[TBL] [Abstract][Full Text] [Related]
4. Adverse effects of low dose methotrexate in rheumatoid arthritis patients.
Gilani ST; Khan DA; Khan FA; Ahmed M
J Coll Physicians Surg Pak; 2012 Feb; 22(2):101-4. PubMed ID: 22313647
[TBL] [Abstract][Full Text] [Related]
5. [Toxicity of low-dose methotrexate in rheumatoid arthritis--clinical characteristics in patients with MTX-induced pancytopenia and interstitial pneumonitis].
Ohosone Y; Okano Y; Kameda H; Hama N; Matsumura M; Nojima T; Nakamura K; Kuwana M; Ogasawara T; Hirakata M; Yoshida T; Mimori T; Akizuki M; Ikeda Y
Ryumachi; 1997 Feb; 37(1):16-23. PubMed ID: 9128419
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate-induced pancytopenia: a case series of 46 patients.
Ajmani S; Preet Singh Y; Prasad S; Chowdhury A; Aggarwal A; Lawrence A; Misra R; Mishra R; Agarwal V
Int J Rheum Dis; 2017 Jul; 20(7):846-851. PubMed ID: 28261918
[TBL] [Abstract][Full Text] [Related]
7. Thrombocytopenia in patients with rheumatoid arthritis on long-term treatment with low dose methotrexate.
Franck H; Rau R; Herborn G
Clin Rheumatol; 1996 May; 15(3):266-70. PubMed ID: 8793258
[TBL] [Abstract][Full Text] [Related]
8. Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
Amital H; Arnson Y; Chodick G; Shalev V
Rheumatology (Oxford); 2009 Sep; 48(9):1107-10. PubMed ID: 19578136
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
Müller RB; von Kempis J; Haile SR; Schiff MH
Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
[TBL] [Abstract][Full Text] [Related]
10. Adverse effects of low dose methotrexate in rheumatoid arthritis patients. A hospital-based study.
Attar SM
Saudi Med J; 2010 Aug; 31(8):909-15. PubMed ID: 20714691
[TBL] [Abstract][Full Text] [Related]
11. [Pancytopenia and Pneumocystis carinii pneumonia associated with low dose methotrexate pulse therapy for rheumatoid arthritis--case report and review of literature].
Kitsuwa S; Matsunaga K; Kawai M; Tsuzi T; Kato K; Tani K; Okubo T
Ryumachi; 1996 Jun; 36(3):551-8. PubMed ID: 8779792
[TBL] [Abstract][Full Text] [Related]
12. Tocilizumab is clinically, functionally, and radiographically effective and safe either with or without low-dose methotrexate in active rheumatoid arthritis patients with inadequate responses to DMARDs and/or TNF inhibitors: a single-center retrospective cohort study (KEIO-TCZ study) at week 52.
Izumi K; Kaneko Y; Yasuoka H; Seta N; Kameda H; Kuwana M; Takeuchi T
Mod Rheumatol; 2015 Jan; 25(1):31-7. PubMed ID: 24684408
[TBL] [Abstract][Full Text] [Related]
13. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms.
Cipriani P; Ruscitti P; Carubbi F; Liakouli V; Giacomelli R
Clin Ther; 2014 Mar; 36(3):427-35. PubMed ID: 24612941
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of leflunomide 100mg weekly compared to low dose methotrexate in patients with active rheumatoid arthritis. Double blind, randomized clinical trial.
Jaimes-Hernández J; Meléndez-Mercado CI; Mendoza-Fuentes A; Aranda-Pereira P; Castañeda-Hernández G
Reumatol Clin; 2012; 8(5):243-9. PubMed ID: 22763150
[TBL] [Abstract][Full Text] [Related]
16. Low-dose methotrexate-induced pancytopenia.
Preet Singh Y; Aggarwal A; Misra R; Agarwal V
Clin Rheumatol; 2007 Jan; 26(1):84-7. PubMed ID: 16636937
[TBL] [Abstract][Full Text] [Related]
17. Thrombocytopenia in patients with rheumatoid arthritis on long-term treatment with low dose methotrexate.
Franck H; Rau R; Herborn G
Clin Rheumatol; 1996 Mar; 15(2):163-7. PubMed ID: 8777850
[TBL] [Abstract][Full Text] [Related]
18. Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.
Zintzaras E; Dahabreh IJ; Giannouli S; Voulgarelis M; Moutsopoulos HM
Clin Ther; 2008 Nov; 30(11):1939-55. PubMed ID: 19108784
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate-related toxicity in patients with rheumatoid arthritis and renal dysfunction.
Lee JS; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
Rheumatol Int; 2020 May; 40(5):765-770. PubMed ID: 32170389
[TBL] [Abstract][Full Text] [Related]
20. Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study.
Branco JC; Barcelos A; de Araújo FP; Sequeira G; Cunha I; Patto JV; Oliveira M; Mateus MP; Couto M; Nero P; Pinto P; Monteiro P; Castelão W; Félix J; Ferreira D; Almeida J; Silva MJ
Adv Ther; 2016 Jan; 33(1):46-57. PubMed ID: 26724937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
